The Government of India has said that the people will not be given a choice on which COVID-19 vaccine tp take. Earlier Indian health regulators approved two vaccine manufactures Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
Health Secretary Rajesh Bhushan said ‘Several countries are using more than one COVID-19 vaccine. In none of these countries are beneficiaries being offered an option of choosing which vaccine to take.’ The Health Ministry bagged 11 million doses of Covishield from Serum Institute at a cost of ₹200 per dose, exclusive of taxes and 3.85 million doses of Covaxin at a cost of ₹206 per dose exclusive of taxes.